GRTX stock forecast for 2023 – 2027

Are you interested in Galera Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the GRTX stock price in 2022-2027. Is GRTX a good long term stock? When should I take profit in Galera Therapeutics stock? Buy or sell stock? Will GRTX stock price go up? What are analysts’ forecasts for GRTX stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. GRTX stock returns are also predicted based on historical data.

According to our research, GRTX stock is a bad long-term investment. GRTX share price has been in a bear cycle for the past year. Galera Therapeutics, Inc. stock trend is negative.

Galera Therapeutics company info

Industry Biotechnology
Address 2 West Liberty Boulevard, Malvern, PA, 19355, United States
Website https://www.galeratx.com

Forecasting

52 Week High: 4.528 USD
52 Week Low: 0.00000101 USD
1 Year Forecast: 0.000000000001 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 72.44M
52 Week Change: -8.799%
52 Week High: 12.99 USD
52 Week Low: 1.19 USD
Beta: 0.260684
50 Day Moving Average: 3.38
90 Day Moving Average: 2.609
200 Day Moving Average: 5.44
Resistance Level: 2.8812
Pivot Point: 2.7438
Support Level: 2.4402
Enterprise Value: 16,373,517
Forward P/E: -1.16
Forward EPS: -2.15
Profit Margin: 0.00%
Shares Outstanding: 26,438,800
EBITDA: -0.21
Held Percent Institutions: 67.30%
PEG Ratio (5Y): -0.08
Trailing EPS: -3.297

Galera Therapeutics stock forecasts for 2023-2027

DateOpen PriceClose PriceChange

Galera Therapeutics Stock Forecast for 2023

January 2023 36.63 0 -100%
February 2023 0 0 -100%
March 2023 0 0 -100%
April 2023 39.39 39.39 0%
May 2023 0 0 0%
June 2023 0 0 0%
July 2023 40.18 0 -100%
August 2023 0 0 -100%
September 2023 0 42.42 -100%
October 2023 41.58 0 -100%
November 2023 0 0 -100%
December 2023 0 44 -100%

Galera Therapeutics Stock Forecast for 2024

January 2024 0 0 -100%
June 2024 48.48 48.48 0%

Other companies stock forecasts